- Home
- FUSB vs ZTEK Comparison
FUSB vs ZTEK Comparison
Compare FUSB & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | ZTEK |
|---|---|---|
| Founded | 1952 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.4M | 68.8M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FUSB | ZTEK |
|---|---|---|
| Price | $15.49 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 66.6K |
| Earning Date | 04-29-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.47 | $0.50 |
| 52 Week High | $15.99 | $1.84 |
Technical Indicators
Market Signals| Indicator | FUSB | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 38.71 |
| Support Level | $14.73 | $0.55 |
| Resistance Level | $15.49 | $0.75 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 92.86 | 33.33 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.